| # | Drug | Count |
|---|---|---|
| 0 | ASFOTASE ALFA | 42 |
| 1 | DENOSUMAB | 26 |
| 2 | ALENDRONATE SODIUM | 17 |
| 3 | ANASTROZOLE | 10 |
| 4 | CYCLOPHOSPHAMIDE | 10 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 7 | DOXORUBICIN | 10 |
| 8 | PACLITAXEL | 10 |
| 9 | TRASTUZUMAB | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASFOTASE ALFA | 42 | 0.0041 |
| 1 | BORON | 1 | 0.0033 |
| 2 | BUFFERED ASPIRIN | 1 | 0.0007 |
| 3 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 4 | ISOFLURANE | 1 | 0.0005 |
| 5 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 6 | FERRIC CARBOXYMALTOSE | 2 | 0.0004 |
| 7 | ANASTROZOLE TABLETS | 9 | 0.0004 |
| 8 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 9 | CALCITRIOL CAPSULES 0.25 MCG | 7 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 42 |
| 1 | RANK Ligand Inhibitor [EPC] | 26 |
| 2 | Aromatase Inhibitor [EPC] | 11 |
| 3 | Alkylating Drug [EPC] | 10 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 10 |
| 5 | Microtubule Inhibitor [EPC] | 10 |
| 6 | Vitamin D3 Analog [EPC] | 7 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 8 | Parathyroid Hormone Analog [EPC] | 5 |
| 9 | Vitamin D [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 42 | 0.0041 |
| 1 | Vitamin D3 Analog [EPC] | 7 | 0.0003 |
| 2 | Calcitonin [EPC] | 1 | 0.0003 |
| 3 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 4 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 5 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 10 | 0.0001 |
| 8 | RANK Ligand Inhibitor [EPC] | 26 | 0.0001 |
| 9 | Aromatase Inhibitor [EPC] | 11 | 0.0001 |